CBLL (CeriBell) Quarterly EPS earnings growth
CeriBell, Inc. (CBLL) generates revenue through cloud-based AI EEG analysis, creating a high-margin SaaS stream. The quarterly EPS change scale visualizes profitability dynamics, where -51.50 represents the current metric. Management is actively implementing neurotechnologies in intensive care units, accelerating expansion. The team is currently restructuring for commercial growth following the IPO, leveraging physician trust.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_CBLL_-_CeriBell-Inc._-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "ceribell.com (CBLL): Year-over-year earnings per share growth for the last twelve months from 10/12/2024 to 11/11/2026 | 👁️GURU.Markets👁️")
CeriBell EEG (CBLL) - metric breakdowns and financial figures
- share price and expert price forecast:
- business market valuation indicators:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Equity Ratio CeriBell, Inc.|CBLL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital CeriBell, Inc.|CBLL - Company Total Debt Obligations|Debt to Book Capitalization Ratio CeriBell Corp|CBLL - Company Long-Term Indebtedness|Company Short-Term Debts CeriBell|Quick Liquidity Indicator ceribell.com
- earnings and market multiples details:
CBLL - Net Financial Result|Projected Future Earnings CeriBell, Inc.|CBLL - Price to Earnings Ratio|Forward P/E Multiple CeriBell Corp|CBLL - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CeriBell Corp|CBLL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months CeriBell|CBLL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months ceribell.com|CBLL - Earnings per share growth this year|Earnings growth forecast for next year CeriBell, Inc.
Analysis of all company metrics:CeriBell, Inc.
Fundamental asset selection is based on an analysis of net profit per share dynamics. This indicator measures the percentage change in EPS between quarters, revealing hidden growth in operating expenses. For CeriBell, Inc. (CBLL), this metric reflects the monetization efficiency of brain monitoring consumables. A steady cash flow from sensors should support a positive profit trajectory. Evaluate the level of quarterly EPS change to avoid purchasing the asset at a local peak.
Key competitors
BIIB: Quarterly EPS earnings growth|NBIX (Neurocrine) - Year-over-year earnings per share growth for the last twelve months|RGC (Regencell) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Corp AXSM|Year-over-year earnings per share growth for the last twelve months ACADIA Pharmaceuticals (ACAD)|Year-over-year earnings per share growth for the last twelve months XENE (xenon-pharma.com)|Year-over-year earnings per share growth for the last twelve months Viking Therapeutics, Inc. VKTX|Supernus Pharmaceuticals, Inc. - Year-over-year earnings per share growth for the last twelve months|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Corp)|HRMY: Quarterly EPS earnings growth|BHVN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx Pharmaceuticals, Inc.|Year-over-year earnings per share growth for the last 12 months TRVI (Trevi Therapeutics Inc)|Quarterly EPS earnings growth PRAX|Year-over-year net earnings per share growth for the last 12 months Anavex Life Sciences Corp AVXL|Prothena Corporation - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Alector Inc. (ALEC)|Annexon - Quarterly EPS earnings growth|Omeros Corporation (OMER) - Year-over-year net earnings per share growth for the last 12 months|NGNE: Quarterly EPS earnings growth|ACIU (AC Immune Inc) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Voyager Therapeutics|Year-over-year earnings per share growth for the last twelve months NMRA|Year-over-year earnings per share growth for the last twelve months Scilex (SCLX)|Year-over-year earnings per share growth for the last twelve months TVGN (Tevogen Bio Holdings Inc.)|Year-over-year earnings per share growth for the last twelve months Alpha Cognition Inc. ACOG|CGTX: Year-over-year earnings per share growth for the last 12 months|Inhibikase Therapeutics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months cassavasciences.com|ASRT (assertiotx.com) - Year-over-year net earnings per share growth for the last 12 months|Coya Therapeutics (COYA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months VistaGen Therapeutics, Inc.|OVID: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals (ABOS)|CRVO - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth ATHE (Alterity Therapeutics Limited)|CLNN - Year-over-year net earnings per share growth for the last 12 months|PepGen Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jupiterneurosciences.com|Relmada Therapeutics (RLMD) - Year-over-year earnings per share growth for the last twelve months|annovisbio.com - Year-over-year earnings per one share growth for the last 12 months|GRCE (Grace Therapeutics Inc) - Quarterly EPS earnings growth|Firefly Neuroscience, Inc. (AIFF) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth KLTO|Year-over-year earnings per share growth for the last twelve months NRSN (neurosense-tx.com)|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals)|MetaVia Inc. (MTVA) - Earnings per share growth in annualized terms for the last twelve months|NRXS - Year-over-year earnings per share growth for the last twelve months|HSDT: Year-over-year earnings per share growth for the last twelve months|passagebio.com (PASG) - Year-over-year earnings per share growth for the last twelve months|NEUP (Neuphoria Therapeutics) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months NERV|ATHA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ADXN|Year-over-year net earnings per share change for the last twelve months alzamend.com|Year-over-year earnings per share growth for the last twelve months Cyclerion Therapeutics, Inc. CYCN|PTIX: Year-over-year earnings per share growth for the last 12 months|Pasithea - Quarterly EPS earnings growth|Cortigent, Inc. (CRGT) - Year-over-year net earnings per share growth for the last 12 months|ATXI (Avenue Therapeutics, Inc.) - Year-over-year net earnings per share growth for the last 12 months|BCLI - Year-over-year net earnings per share change for the last twelve months|CARA (Cara Therapeutics, Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Chromocell (CHRO)|Quarterly EPS earnings growth ELYM|Year-over-year earnings per share growth for the last twelve months ITCI (intracellulartherapies.com)|Year-over-year earnings per share growth for the last twelve months Longboard Pharmaceuticals, Inc. LBPH|Marinus Pharmaceuticals Inc - Year-over-year earnings per share growth for the last twelve months|NKGN - Year-over-year earnings per share growth for the last twelve months|NRBO: Year-over-year earnings per share growth for the last twelve months|Sage Therapeutics, Inc. (SAGE) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months SNPX|TRVN (Trevena) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Vigil Neuro VIGL|Year-over-year net earnings per share growth for the last 12 months WENA (Anew Medical, Inc.)|Quarterly EPS earnings growth Cerevel Corp (CERE)
